Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

petco health & wellness company inc - WOOF

WOOF

Close Chg Chg %
2.79 0.02 0.72%

Pre-Market

2.81

+0.02 (0.72%)

Volume: 1.80M

Last Updated:

Mar 25, 2026, 4:00 PM EDT

Trade Now

Company Overview: petco health & wellness company inc - WOOF

WOOF Key Data

Open

$2.84

 Day Range

2.76 - 2.88

52 Week Range

2.24 - 4.51

 Market Cap

$793.35M

Shares Outstanding

284.36M

 Public Float

140.47M

Beta

1.75

 Rev. Per Employee

N/A

P/E Ratio

88.01

 EPS

$0.03

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

4.54M

  

WOOF Performance

1 Week
 
 -4.45%
 
1 Month
 
 9.41%
 
3 Months
 
 -4.78%
 
1 Year
 
 -5.74%
 
5 Years
 
 -86.71%
 

WOOF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About petco health & wellness company inc - WOOF

Petco Health & Wellness Company, Inc. engages in the provision of pet health and wellness services. It operates across the U.S., Mexico and Puerto Rico, including a growing network, store veterinary hospitals, and offer a complete online resource for pet health and wellness. The firm offers grooming, as well as in-store and online training. The company was founded in 1965 and is headquartered in San Diego, CA.

WOOF At a Glance

Petco Health & Wellness Company, Inc.
10850 Via Frontera
San Diego, California 92127
Phone 1-858-453-7845 Revenue 5.96B
Industry Internet Retail Net Income 9.07M
Sector Retail Trade Employees 29,000
Fiscal Year-end 01 / 2027
View SEC Filings

WOOF Valuation

P/E Current 88.013
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 84.858
Price to Sales Ratio 0.129
Price to Book Ratio 0.65
Price to Cash Flow Ratio 2.45
Enterprise Value to EBITDA 10.16
Enterprise Value to Sales 0.565
Total Debt to Enterprise Value 0.851

WOOF Efficiency

Revenue/Employee 205,567.828
Income Per Employee 312.621
Receivables Turnover 113.96
Total Asset Turnover 1.048

WOOF Liquidity

Current Ratio 0.899
Quick Ratio 0.379
Cash Ratio 0.238

WOOF Profitability

Gross Margin 38.666
Operating Margin 2.257
Pretax Margin -0.084
Net Margin 0.152
Return on Assets 0.159
Return on Equity 0.796
Return on Total Capital 0.225
Return on Invested Capital 0.244

WOOF Capital Structure

Total Debt to Total Equity 246.121
Total Debt to Total Capital 71.108
Total Debt to Total Assets 50.571
Long-Term Debt to Equity 218.233
Long-Term Debt to Total Capital 63.051
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Petco Health & Wellness Company Inc - WOOF

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
6.04B 6.26B 6.12B 5.96B
Sales Growth
+3.94% +3.63% -2.22% -2.53%
Cost of Goods Sold (COGS) incl D&A
3.60B 3.90B 3.79B 3.66B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
193.83M 200.78M 199.73M 196.71M
Depreciation
193.83M 200.78M 199.73M 196.71M
Amortization of Intangibles
- - - -
-
COGS Growth
+6.51% +8.35% -2.80% -3.58%
Gross Income
2.44B 2.35B 2.32B 2.31B
Gross Income Growth
+0.36% -3.35% -1.25% -0.83%
Gross Profit Margin
+40.35% +37.63% +38.00% +38.67%
2023 2024 2025 2026 5-year trend
SG&A Expense
2.17B 2.27B 2.28B 2.17B
Research & Development
- - - -
-
Other SG&A
2.17B 2.27B 2.28B 2.17B
SGA Growth
+1.02% +4.68% +0.27% -4.80%
Other Operating Expense
- - - -
-
Unusual Expense
50.34M 1.26B 32.73M 14.70M
EBIT after Unusual Expense
212.89M (1.18B) 11.85M 119.87M
Non Operating Income/Expense
1.03M 3.89M 6.86M 6.86M
Non-Operating Interest Income
1.03M 3.40M 3.71M 6.30M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
101.64M 151.40M 146.68M 131.75M
Interest Expense Growth
+31.33% +48.95% -3.12% -10.17%
Gross Interest Expense
101.64M 151.40M 146.68M 131.75M
Interest Capitalized
- - - -
-
Pretax Income
112.28M (1.32B) (127.97M) (5.03M)
Pretax Income Growth
-44.52% -1,279.19% +90.33% +96.07%
Pretax Margin
+1.86% -21.17% -2.09% -0.08%
Income Tax
35.35M (27.61M) (7.48M) 6.27M
Income Tax - Current - Domestic
36.24M 25.94M 21.18M (13.10M)
Income Tax - Current - Foreign
- - 1.84M 2.32M
-
Income Tax - Deferred - Domestic
(893.00K) (53.55M) (30.49M) 17.05M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
89.91M (1.28B) (101.82M) 9.07M
Minority Interest Expense
- - - (891.00K)
-
Net Income
90.80M (1.28B) (101.82M) 9.07M
Net Income Growth
-44.77% -1,509.91% +92.05% +108.90%
Net Margin Growth
+1.50% -20.47% -1.66% +0.15%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
90.80M (1.28B) (101.82M) 9.07M
Preferred Dividends
- - - -
-
Net Income Available to Common
90.80M (1.28B) (101.82M) 9.07M
EPS (Basic)
0.342 -4.785 -0.3724 0.0324
EPS (Basic) Growth
-44.88% -1,499.12% +92.22% +108.70%
Basic Shares Outstanding
265.52M 267.55M 273.41M 279.56M
EPS (Diluted)
0.3414 -4.785 -0.3724 0.0317
EPS (Diluted) Growth
-44.98% -1,501.58% +92.22% +108.51%
Diluted Shares Outstanding
265.95M 267.55M 273.41M 286.15M
EBITDA
457.06M 280.88M 244.31M 331.28M
EBITDA Growth
+1.82% -38.55% -13.02% +35.60%
EBITDA Margin
+7.57% +4.49% +3.99% +5.56%

Snapshot

Average Recommendation HOLD Average Target Price 3.535
Number of Ratings 12 Current Quarters Estimate 0.015
FY Report Date 04 / 2026 Current Year's Estimate 0.203
Last Quarter’s Earnings 0.058 Median PE on CY Estimate N/A
Year Ago Earnings 0.168 Next Fiscal Year Estimate 0.288
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 11 11
Mean Estimate 0.01 0.08 0.20 0.29
High Estimates 0.04 0.13 0.34 0.75
Low Estimate -0.02 0.05 0.08 0.07
Coefficient of Variance 134.41 27.74 35.27 60.68

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 2 2
OVERWEIGHT 0 0 0
HOLD 7 8 8
UNDERWEIGHT 1 1 1
SELL 1 1 2
MEAN Hold Hold Hold

Insider Actions for Petco Health & Wellness Company Inc - WOOF

Date Name Shares Transaction Value
Feb 20, 2026 Patrick Joseph Venezia Chief Revenue Officer 355,732 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Giovanni Insana See Remarks 124,514 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Giovanni Insana See Remarks 189,724 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Holly May Chief Human Resources Officer 132,296 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Holly May Chief Human Resources Officer 201,582 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Michael F. Romanko See Remarks 466,927 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Michael F. Romanko See Remarks 711,463 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Patrick Joseph Venezia Chief Revenue Officer 233,464 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Sabrina L. Simmons Chief Financial Officer 389,106 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Sabrina L. Simmons Chief Financial Officer 592,886 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Joel D. Anderson Chief Executive Officer; Director 1,400,779 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Joel D. Anderson Chief Executive Officer; Director 2,134,388 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 29, 2025 Rajendra Michael Mohan Director 523,027 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 29, 2025 Gary S. Briggs Director 162,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 29, 2025 Cameron Breitner Director 92,676 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 29, 2025 Iris Yen Director 145,787 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 Joel D. Anderson Chief Executive Officer; Director 7,874 Open market or private purchase of non-derivative security Non-derivative transaction at $3.03 per share 23,858.22
Apr 2, 2025 Joel D. Anderson Chief Executive Officer; Director 724,910 Open market or private purchase of non-derivative security Non-derivative transaction at $3.03 per share 2,196,477.30

Petco Health & Wellness Company Inc in the News